Literature DB >> 7146731

Eradication of poliomyelitis in the United States.

N Nathanson.   

Abstract

Mass immunization with oral poliovirus vaccine (OPV) was begun in the United States in 1963, and the least natural outbreak of poliomyelitis occurred in 1972. Since immunization programs fail to reach the total population, eradication has been achieved in the presence of a residual susceptible population of at least 5% (2-5 million children under the age of 15 years). It is proposed that the fade-out of wild polioviruses is explained by their disappearance during the winter, a low point in the yearly cycle of the virus. In the post-eradication era, the continued presence of millions of susceptible children and adults presents a constant potential hazard. Every effort should be made to maintain maximal levels of immunization with oral poliovirus vaccine and to prevent the reintroduction of wild polioviruses into the United States.

Entities:  

Keywords:  Americas; Delivery Of Health Care; Developed Countries; Developing Countries; Diseases; Evaluation; Geographic Factors; Health; Health Services; Immunization; Measurement; Medicine; North America; Northern America; Organization And Administration; Population; Preventive Medicine; Primary Health Care; Program Effectiveness; Program Evaluation; Programs; Qualitative Evaluation; Research Methodology; Seasonal Variation; Spatial Distribution; United States; Vaccination; Viral Diseases--prevention and control

Mesh:

Substances:

Year:  1982        PMID: 7146731     DOI: 10.1093/clinids/4.5.940

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  9 in total

Review 1.  Herd immunity and herd effect: new insights and definitions.

Authors:  T J John; R Samuel
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  The case for global eradication of poliomyelitis.

Authors:  A R Hinman; W H Foege; C A de Quadros; P A Patriarca; W A Orenstein; E W Brink
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

3.  A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases.

Authors:  R W Sutter; E W Brink; S L Cochi; O M Kew; W A Orenstein; R J Biellik; A R Hinman
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

Review 4.  From emergence to eradication: the epidemiology of poliomyelitis deconstructed.

Authors:  Neal Nathanson; Olen M Kew
Journal:  Am J Epidemiol       Date:  2010-10-26       Impact factor: 4.897

5.  Putting together the pieces of polio: how Dorothy Horstmann helped solve the puzzle.

Authors:  Heather A Carleton
Journal:  Yale J Biol Med       Date:  2011-06

6.  Does Herd Immunity Exist in Aquatic Animals?

Authors:  Isaac F Standish; Travis O Brenden; Mohamed Faisal
Journal:  Int J Mol Sci       Date:  2016-11-15       Impact factor: 5.923

7.  Viral replicons as valuable tools for drug discovery.

Authors:  Holger Hannemann
Journal:  Drug Discov Today       Date:  2020-04-06       Impact factor: 7.851

Review 8.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072

9.  Characteristics of Patients with Acute Flaccid Myelitis, United States, 2015-2018.

Authors:  Nilay McLaren; Adriana Lopez; Sarah Kidd; John X Zhang; W Allan Nix; Ruth Link-Gelles; Adria Lee; Janell A Routh
Journal:  Emerg Infect Dis       Date:  2020-02       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.